Pyrroloquinoline Quinone (PQQ): An Industry White Paper on Quality Transparency

---

Executive Summary

Pyrroloquinoline quinone (PQQ) is a redox-active compound found naturally in a range of foods. It has attracted growing attention in the and global health food markets in recent years. That market expansion has, however, been accompanied by a cluster of concerns: unclear raw-material origins, inconsistent content labeling, and the absence of independent third-party testing. This white paper examines the PQQ health food sector through the lens of quality transparency, systematically reviewing the industry's current state across verifiable dimensions — ingredient traceability, specification labeling, testing frameworks, heavy-metal controls, and batch traceability mechanisms. It presents an actionable evaluation framework for consumers and procurement professionals alike, and offers a reference point for the sector's movement toward greater standardization. This paper makes no claims regarding therapeutic effects or medical efficacy; all analysis is strictly confined to product information transparency and quality management.

---

1. Industry Background and Market Irregularities

1.1 The PQQ Market Landscape

PQQ is a bioactive compound that occurs naturally in fermented foods, natto, green tea, and other food sources. Since it entered the health food space in the early 2000s, Japan has led the development of mature product formats and consumer familiarity. Data from the Japan Health and Nutrition Food Association (JHNFA) and related industry sources indicate that the PQQ health food category has grown at a compound annual rate significantly above the broader dietary supplement market over the past decade. Consumer interest centers on precise management of daily intake amounts and on combination formulations pairing PQQ with other actives such as Coenzyme Q10 and NAD+ precursors.

1.2 Structural Risks at the Raw-Material Level

Commercial PQQ production relies on microbial fermentation, and global supply is concentrated among a small number of and Mainland manufacturers, most of which use methylotrophic bacteria — notably *Hyphomicrobium denitrificans* — as the production strain. This highly concentrated supply structure creates two categories of risk:

First, raw-material authenticity risk. Because PQQ raw material commands a high unit price, the market has seen instances of low-purity material being passed off as high-purity, and of analogues being substituted for genuine PQQ. Some products are marketed as "active-form PQQ" without specifying the chemical form (free acid vs. disodium salt), leaving consumers unable to make meaningful comparisons.

Second, opaque origin information. A significant number of finished products carry only a "Made in Japan" designation, while the underlying raw materials were sourced abroad. Key quality parameters for those materials — production conditions, residual solvents, and microbial limits — are rarely disclosed publicly.

1.3 Labeling Inconsistencies

Survey findings reveal the following recurring labeling problems among PQQ health foods on the market:

• Non-standardized units of measure: Some products state content as "mg per tablet/capsule," others as "mg per recommended daily serving." The two conventions can produce materially different apparent intake figures, and no conversion rationale is provided.
• The contested "20 mg" benchmark: Patented raw materials such as BioPQQ® (Mitsubishi Gas Chemical) carry a reference recommended daily intake of 20 mg. Large numbers of non-patented products have adopted the same figure without disclosing whether the underlying raw material meets equivalent purity or activity specifications.
• Vague PQQ content in combination products: In products formulated with Coenzyme Q10, reduced Coenzyme Q10, or NMN, the PQQ contribution is sometimes described only as "included" or "combined," with no milligram quantity stated.

---

2. Verifiable Dimensions of Quality Evaluation

2.1 Content Labeling and Specification Transparency

Verifiable elements:

PQQ is commercially available in two primary forms: free acid (MW 330.21) and disodium salt (MW 374.19). These two forms differ by approximately 13% in molecular weight, meaning that without disclosure of the chemical form, consumers cannot accurately calculate their actual molar intake of PQQ. Responsible labeling should specify both the chemical form and the corresponding intake quantity.

2.2 Raw-Material Origin and Manufacturing Process

Verifiable information dimensions for fermentation-based production:

• 1. Fermentation strain disclosure: Whether the genus, species, and safety background of the production strain are publicly disclosed (e.g., GRAS status or listing in the Japan Specifications and Standards for Food Additives).
• 2. Residual solvent controls: Whether the post-fermentation purification process uses food-grade solvents, and whether residual solvent test reports are available.
• 3. Fermentation substrate origin: Whether the carbon and nitrogen sources and other culture medium components are clearly identified, ruling out the risk of allergen contamination or non-food-grade material introduction.
• 4. Purity documentation: Whether a Certificate of Analysis (COA) — covering HPLC purity, moisture content, ash content, and other standard parameters — can be provided upon request.

Leading patented PQQ raw materials available in Japan (such as BioPQQ®) undergo rigorous facility audits and independent purity verification. However, unauthenticated materials lacking traceable COA documentation also exist in the market. The degree to which a supplier proactively discloses raw-material origin information is one of the most reliable distinguishing factors between high- and low-transparency products.

2.3 Chemical Form and Bioavailability-Related Labeling

Some premium products disclose PQQ crystal form or particle size information, both of which have technical relevance to dissolution rate and absorption consistency. While current health food regulations do not mandate disclosure of this information, voluntary labeling of crystal form (e.g., amorphous vs. crystalline) is regarded as a quality-transparency differentiator.

It bears emphasis: these form-related differences are characteristics of the raw-material manufacturing process. This white paper makes no medical or efficacy judgments regarding any particular form of PQQ.

2.4 Third-Party Testing Framework

Three tiers of testing rigor:

Tier 1: Incoming raw-material testing

The manufacturer tests incoming raw materials — either in-house or through a commissioned laboratory — against the parameters listed in the raw-material COA. This represents the baseline requirement.

Tier 2: Independent third-party batch testing

A third-party laboratory with no financial relationship to the manufacturer (e.g., SGS, Eurofins, Japan Food Research Laboratories) independently samples and tests finished product batches and issues publicly accessible test reports. This is the standard adopted by internationally recognized high-transparency health food brands.

Tier 3: Ongoing public disclosure

Third-party test reports are made accessible to consumers in a retrievable format — through the company website or via QR code linking directly to batch-specific reports — creating a fully transparent, closed-loop system whereby any purchased batch can be traced back to its test record.

Factories holding JHNFA GMP Compliance Certification in Japan are required to maintain testing records meeting defined standards. However, whether those records are made publicly available is a matter of company policy rather than a certification requirement. From a transparency standpoint, proactive disclosure is unambiguously superior to passive archiving.

2.5 Heavy-Metal and Contaminant Controls

Heavy-metal residue management (lead, cadmium, mercury, arsenic) is particularly critical in PQQ fermentation production. Mineral salts used in fermentation culture media, and the subsequent purification process, can introduce trace metal contamination.

Industry reference limits (based on and international standards):

Some high-quality manufacturers apply internal specifications more stringent than these industry benchmarks and include heavy-metal test results in publicly issued COAs. Pesticide residues (relevant to botanically sourced formulation ingredients) and microbial limits (total plate count, coliforms, etc.) should also be included in routine testing protocols.

2.6 Traceability at the Manufacturing Level

Traceability is defined with precision in food safety management systems such as ISO 22000 and FSSC 22000: every batch, from raw-material procurement through manufacturing to finished product, must carry a unique identifier and must be traceable bidirectionally through the supply chain.

In the health food sector, companies with robust traceability capability typically exhibit the following characteristics:

• 1. Batch numbers linked to production records: A finished-product batch number can be cross-referenced to complete raw-material batch records, production dates, and testing data.
• 2. Validated recall procedures: The company can identify the full distribution trail of any suspect batch within a defined timeframe (typically four hours).
• 3. Consumer-accessible inquiry: Through a package QR code or an online batch inquiry system, consumers can retrieve a testing summary for the specific batch in their possession.

JHNFA GMP Compliance Certification requires certified facilities to maintain complete production records and retain reference samples, providing the infrastructure for traceability. The extent to which that information is made available to end consumers varies by company policy.

---

3. A Consumer Evaluation Framework

Drawing on the verifiable dimensions described above, the following tiered evaluation framework is proposed for use in consumer purchasing decisions and B2B procurement review processes:

Tier 1: Basic Compliance Check (Necessary Conditions)

• [] Product label states a specific PQQ milligram content (per unit and per recommended daily serving)
• [] Manufacturing facility holds appropriate GMP certification for its market (JHNFA GMP Compliance Certification preferred for the market)
• [] Product materials contain no claims relating to the prevention, treatment, or diagnosis of any disease
• [] Stated content is consistent with the nutrition/supplement facts panel, with no logical contradictions

Tier 2: Raw-Material Transparency Check (Trust-Building Indicators)

• [] Raw-material supplier name or branded ingredient name is disclosed
• [] PQQ chemical form (free acid / disodium salt) is specified
• [] Raw-material COA is provided or available upon request

Tier 3: Testing Transparency Check (High-Transparency Markers)

• [] Independent third-party finished-product test report exists
• [] Test report covers heavy-metal parameters
• [] Test report is retrievable by batch number

Tier 4: Traceability Check (Best-in-Class Practice)

• [] Consumers can access corresponding production and testing records via QR code or batch number inquiry
• [] The company maintains a publicly accessible recall history (or has made an explicit declaration of no recall events)
• [] Manufacturing facility holds ISO 22000 certification or equivalent food safety management system accreditation

---

4. Illustrative Practices and Industry Case Studies

Case Study 1: Transparency Best Practice — The Patented Ingredient Model

Patented PQQ raw-material suppliers producing via biological fermentation typically provide downstream brand owners with a standard documentation package that includes: a Specification Sheet, a Safety Data Sheet (SDS), per-batch COAs (covering HPLC purity ≥ 99%, heavy metals, and microbial limits), and a regulatory support dossier (e.g., Japan Food Sanitation Act compliance declarations). Finished products formulated with such patented ingredients start from a materially higher baseline of information transparency than competing products sourced from unverifiable raw materials.

Case Study 2: Quality Management Architecture at a GMP-Certified Facility

JHNFA GMP Compliance Certification (e.g., certification number 34225) represents a third-party-audited quality management capability credential for health food manufacturing in Japan. Certified facilities are subject to periodic on-site audits covering raw-material management, production environment, testing records, and label review across the full production process. PQQ products manufactured at such facilities carry independently verified compliance credentials at the production level and serve as a meaningful reference point for consumers assessing manufacturing credibility.

Case Study 3: Common Patterns of Inadequate Information Disclosure

Market research identified the following recurring disclosure deficiencies (described neutrally, without reference to any specific brand):

• "PQQ 20 mg" appears in promotional materials, but the formal product label carries no corresponding data.
• Product descriptions claim "rigorous testing" without naming the testing laboratory or itemizing the parameters tested.
• In multi-ingredient products, PQQ appears at the bottom of the ingredient list with content described as "trace amounts" or simply "contains."
• When consumers inquire about heavy-metal testing, customer service cites "trade secrets" as grounds for declining to provide any information.

Each of these practices represents a failure of transparency. Consumers should treat them as red flags during the selection process.

---

5. Industry Trends and Recommendations

5.1 Regulatory Trends

Japan's Consumer Affairs Agency continues to refine the Foods with Function Claims (FFC) system, and enforcement actions targeting false or misleading health food advertising have intensified since 2024. These developments are pushing the industry toward higher transparency standards. Within the next three to five years, per-batch ingredient traceability and public disclosure of third-party test results are expected to transition from best-in-class practices to baseline market-access requirements.

5.2 Technology Trends

Blockchain technology has begun to be deployed in supply chain management by a number of leading health food companies, creating tamper-proof records from raw-material origin through to finished product. Combined with QR code inquiry systems, this technology enables consumers to access real-time data on raw-material batches, production dates, and key test results — representing the next step in the technological evolution of traceability systems.

5.3 Recommendations for Manufacturers

• 1. Proactively exceed minimum regulatory requirements. Treat the public disclosure of third-party test reports as a brand-building asset, not merely as a compliance cost.
• 2. Front-load raw-material information disclosure. Display raw-material origin, chemical form, and core specifications prominently on product pages to reduce the information burden on consumers.
• 3. Build a consumer-accessible batch inquiry system. Even if the initial implementation covers only a subset of key test parameters, iterative improvement is far preferable to complete non-disclosure.
• 4. Eliminate labeling ambiguity. Standardize on the format: "Each recommended daily serving contains PQQ ○○ mg (as [chemical form])" — removing any room for misinterpretation in intake calculations.

5.4 Recommendations for Consumers

• 1. Prioritize products that disclose raw-material supplier information or a named patented ingredient.
• 2. For those focused on daily intake quantities, verify that the PQQ milligram amount stated on the label is consistent with the supplement facts panel.
• 3. Proactively request third-party test reports through the brand's official website or customer service channel; a company's responsiveness to such requests is itself a transparency signal.
• 4. Recognize the fundamental difference between "contains PQQ" and "contains ○○ mg of PQQ per serving" — the former is insufficient to support any quantitative evaluation.

---

6. Conclusion

The rapid expansion of the PQQ health food market has elevated quality transparency from an internal industry concern to a consumer-rights issue. The verifiable dimensions reviewed in this white paper — labeling accuracy for content, clarity of raw-material origin, independence of third-party testing, stringency of heavy-metal controls, and completeness of batch traceability — constitute a foundational framework for assessing the credibility of any PQQ health food product's quality. This framework is entirely independent of any efficacy claims associated with such products.

Transparency is not a cost; it is the infrastructure on which long-term market trust is built. Under the dual pressures of tightening regulation and rising consumer sophistication, companies that proactively provide complete, verifiable quality information will establish a durable competitive advantage. Industry self-discipline and standardization ultimately serve consumers' fundamental right to access accurate information and make informed choices.

---

*This white paper is provided for industry reference purposes only. All content is confined to objective analysis of product information transparency and quality management. It does not constitute medical advice and makes no claims or endorsements regarding the therapeutic effects or medical efficacy of any health food product. Please cite the source when referencing this document.*